Delivery Order SPE2DB20D2104-SPE2DB25FMWYD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $3,649.00 and an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $4,378.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes on July 30, 2025, with an ultimate completion date of August 20, 2025. This is a non-set-aside contract executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle valued through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes. This competitive, firm fixed-price delivery order, issued on July 22, 2025, is scheduled for completion by August 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition to this established...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,473.50 Firm Fixed Price Delivery Order is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a medical product. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $18,245.00 and a performance period ending on May 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract, valued at $10,947.00, is for the delivery of GEL-ONE 30 MG/3 ML SYRINGE 3ML medical supplies. The award is a firm fixed-price delivery order contract, without a set-aside designation, and has an ultimate completion date of August 6, 2025. Amerisourcebergen Drug Corp is the prime contractor,...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for GEL-ONE 30 MG/3 ML SYRINGE 3ML. The potential value of this contract is $1,763.60 and the completion date is March 12, 2024. Amerisourcebergen Drug Corp provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense, through indefinite delivery...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $10,228.88 contract is for the supply of GEL-ONE 30 MG/3 ML SYRINGE 3ML, a pharmaceutical product, with a completion date of May 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025 for a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $5,290.80 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 4564131699 GEL-ONE 30 MG/3 ML SYRINGE 3ML medical products, with a completion date of April 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $2,116.32 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4563681046 - GEL-ONE 30 MG/3 ML SYRINGE 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWYDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,824.50 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitive contract award, which carries no set-aside designation, is structured as a firm fixed price delivery order. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary distribution operations. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. As a prime vendor in the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor supplying a comprehensive range of medications and medical supplies to support military healthcare programs globally. The company's federal procurement portfolio demonstrates consistent capability in delivering diverse pharmaceutical products, medical devices, and supplies to support Defense Health Agency operations and other federal healthcare systems through competitively awarded contracts with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/30/25 |